Heart Disease News and Research

Latest Heart Disease News and Research

Ethicon Endo-Surgery SEDASYS CAPS system receives European Union CE Mark, Health Canada approval

Ethicon Endo-Surgery today announced that the SEDASYS® System, the first computer-assisted personalized sedation (CAPS) system, was granted a CE Mark for the European Union for routine colonoscopy and screening of the upper gastrointestinal tract (EGD procedures), and Health Canada granted regulatory approval for the SEDASYS® System for use by healthcare professional teams during routine colonoscopy.

3 May 2010

SonoSite, Physio-Control announce development collaboration for point-of-care ultrasound in EMS market

SonoSite, Inc., the world leader and specialist in hand-carried ultrasound for the point-of-care, and Physio-Control, Inc., the global leader in the development and delivery of emergency medical response solutions, today announced a market development collaboration for point-of-care ultrasound in the emergency medical services (EMS) market. This alliance will enable SonoSite to expand its presence in the pre-hospital settings with the support of Physio-Control resources and extensive sales force.

3 May 2010

Stealth interventions may help people eat better, exercise more: Study

How do you get college students to eat better? A new study from the Stanford University School of Medicine suggests that a "stealth" strategy of raising the students' awareness of environmental and social issues related to food can persuade them to eat more veggies and less ice cream.

3 May 2010

TGRD presents positive results from Phase 3 studies of azilsartan medoxomil for lowering SBP at 25th ASH

Takeda Global Research & Development Center, Inc., U.S., (TGRD U.S.) today announced results from pivotal phase 3 studies of azilsartan medoxomil (development code: TAK-491), an angiotensin II receptor blocker (ARB), demonstrating greater 24-hour systolic blood pressure (SBP) reduction compared to commonly prescribed ARBs olmesartan medoxomil and valsartan.

3 May 2010

Implementation of quality improvement intervention reduces medication use in premature babies: Study

A new study by Pediatrix Medical Group researchers has found that the implementation of a quality improvement intervention significantly reduces the use of a large number of medications in premature babies across a broad neonatal intensive care network.

3 May 2010

Intouch Health completes $10M private placement through Beringea-led financing round

InTouch Technologies®, Inc. (d.b.a. InTouch Health®), the world leader in Remote Presence Total Telemedicine solutions, announced today the completion of a private placement of $10 million. The financing round was led by Michigan-based Beringea through its InvestMichigan! Growth Capital Fund, which provides venture and expansion-stage capital to businesses with operations in Michigan.

3 May 2010

MEDNAX first-quarter revenue increases 10% to $332.9 million

MEDNAX, Inc. today reported non-GAAP earnings of 82 cents per share for the 2010 first quarter that was principally the result of revenue growth from acquisitions as well as operating efficiencies generated through the effective management of the Company's administrative infrastructure.

3 May 2010

Belatacept preserves kidney function in transplant recipients better than cyclosporine, says study

Two-year results from phase III clinical trials show the experimental immunosuppressive drug belatacept can better preserve kidney function in kidney transplant recipients while preventing graft rejection when compared with the standard immunosuppressive drug cyclosporine.

3 May 2010

Scientist to receive 2010 March of Dimes Prize in Developmental Biology

The scientist who reprogrammed adult cells into embryonic-like stem cells has been chosen to receive the 2010 March of Dimes Prize in Developmental Biology.

3 May 2010

New classification of depressive subtypes of depression proposed

Lichtenberg and Belmaker propose a new classification of depressive subtypes of depression in the current issue of Psychotherapy and Psychosomatics. They argue that a simple diagnosis is no longer sufficient to guide treatment.

3 May 2010

Investigators examine effects of family-oriented interventions on adults with chronic physical diseases

In the current issue of Psychotherapy and Psychosomatics a group of German investigators examines the literature concerned with the effects of interventions involving the family in the treatment of patients with chronic disease.

3 May 2010

Medical education becomes reality at new Mayo Clinic Multidisciplinary Simulation Center in Arizona

How medical education will be delivered in the 21st Century is now a reality at the new Mayo Clinic Multidisciplinary Simulation Center in Arizona. The 3,000 square-foot facility, embedded within Mayo Clinic Hospital in northeast Phoenix, simulates real-life patient care situations, allowing learners to practice on sophisticated mannequins in a no-risk environment.

3 May 2010

Triple combination therapy with OM, AML, HCTZ more effective at lowering blood pressure

Results of a new study found that the investigational triple combination therapy of olmesartan medoxomil (OM), amlodipine besylate (AML), and hydrochlorothiazide (HCTZ) demonstrated significantly greater mean reductions at week 12 in blood pressure (37.1/21.8 mm Hg versus 27.5 to 30.0/15.1-18.0 mm Hg LS Mean Reductions, P< 0.0001), as compared to corresponding dual combination therapy (dual components).

3 May 2010

EHR with controlled interventions can produce optimal BP control, reduce mortality

Electronic health records with controlled interventions can produce optimal blood pressure control and reduce mortality, according to data presented at the American Society of Hypertension Inc.'s 25th Annual Scientific Meeting and Exposition (ASH 2010).

3 May 2010

MedAire launches new course to prepare pilots, flight attendants for medical emergencies

MedAire, the aviation medical and travel assistance company, has launched the 2010 version of its Management of In-flight Illness & Injury course, which offers medical and educational best practices through the use of audio-visual tools, e-Learning, hands-on skills assessments and real-life scenarios to prepare pilots and flight attendants for medical emergencies.

3 May 2010

Study shows link between short cycles of sleep, stroke and SCI in elderly hypertensive patients

Data presented today at the American Society of Hypertension, Inc.'s 25th Annual Scientific Meeting and Exposition demonstrate a link between short cycles of sleep, stroke and silent cerebral infarct, or "silent strokes," in elderly hypertensive patients.

3 May 2010

Leptin hormone controls immune’s response to sepsis: Study

The hormone leptin, typically associated with body weight regulation, works within the central nervous system (CNS) to aid the immune system's defense against sepsis, researchers say.

3 May 2010

AVANIR Pharmaceuticals announces filing of Complete Response to FDA Approvable Letter for Zenvia

AVANIR Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced the submission of its Complete Response to the October 2006 Approvable Letter issued by the U.S. Food and Drug Administration (FDA) for Zenvia™ (dextromethorphan/quinidine) for the treatment of pseudobulbar affect (PBA). AVANIR expects the FDA to classify the response as a Class 2 resubmission, which would result in an expected review period of 180 days and potential approval of Zenvia in the fourth calendar quarter of 2010.

3 May 2010

Researchers explore use of nanomedicine techniques for treatment of diseases in children

"Children are not small adults"—pediatricians say that's what makes their specialty different from the practice of medicine in adults. For similar reasons, researchers exploring the medical uses of nanotechnology believe that the use of molecular-level nanomedicine techniques in children will also require its own specialty.

3 May 2010

Left ventricular mass may help predict future cardiovascular and renal outcomes: Study

Data presented today at the American Society of Hypertension, Inc.'s 25th Annual Scientific Meeting and Exposition (ASH 2010) indicate that in men with high cardiovascular risk, left ventricular mass may help better predict future cardiovascular and renal outcomes, including hemodialysis.

3 May 2010

Heart Disease News and Research

Latest Heart Disease News and Research

Ethicon Endo-Surgery SEDASYS CAPS system receives European Union CE Mark, Health Canada approval

SonoSite, Physio-Control announce development collaboration for point-of-care ultrasound in EMS market

Stealth interventions may help people eat better, exercise more: Study

TGRD presents positive results from Phase 3 studies of azilsartan medoxomil for lowering SBP at 25th ASH

Implementation of quality improvement intervention reduces medication use in premature babies: Study

Intouch Health completes $10M private placement through Beringea-led financing round

MEDNAX first-quarter revenue increases 10% to $332.9 million

Belatacept preserves kidney function in transplant recipients better than cyclosporine, says study

Scientist to receive 2010 March of Dimes Prize in Developmental Biology

New classification of depressive subtypes of depression proposed

Investigators examine effects of family-oriented interventions on adults with chronic physical diseases

Medical education becomes reality at new Mayo Clinic Multidisciplinary Simulation Center in Arizona

Triple combination therapy with OM, AML, HCTZ more effective at lowering blood pressure

EHR with controlled interventions can produce optimal BP control, reduce mortality

MedAire launches new course to prepare pilots, flight attendants for medical emergencies

Study shows link between short cycles of sleep, stroke and SCI in elderly hypertensive patients

Leptin hormone controls immune’s response to sepsis: Study

AVANIR Pharmaceuticals announces filing of Complete Response to FDA Approvable Letter for Zenvia

Researchers explore use of nanomedicine techniques for treatment of diseases in children

Left ventricular mass may help predict future cardiovascular and renal outcomes: Study

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Heart Disease News and Research

Latest Heart Disease News and Research

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Newsletters you may be interested in